Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 1937-1941, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laryea, M. D.
Right arrow Articles by Wendel, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laryea, M. D.
Right arrow Articles by Wendel, U.
Related Collections
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 1998;44:1937-1941.)
© 1998 American Association for Clinical Chemistry, Inc.

Drug Monitoring and Toxicology

Simple method for the routine determination of betaine and N,N-dimethylglycine in blood and urine

Maurice D. Laryeaa, Folkert Steinhagen, Sandra Pawliczek, and Udo Wendel

a Author for correspondence. Fax 049-0211-811910; e-mail Laryea{at}uni-duesseldorf.de.

A simple and convenient method using commercially available derivatization reagents is described for the measurement of betaine and N,N-dimethylglycine (DMG) in blood and urine. Precolumn derivatization of plasma or urine is performed directly in acetonitrile without extraction with p-bromophenacyl bromide and crown ether as catalyst. The p-bromophenacyl ester derivatives are then separated by high-performance liquid chromatography, using an isocratic system of acetonitrile and water containing choline. Effluent was monitored at 254 nm. The limit of detection was 5 µmol/L for betaine and 2 µmol/L for DMG. Analytical recovery was >97% for both analytes. Total and within-day CVs were 2.0–4.4% and 0.9–2.2% for DMG. For betaine, the total and within-day CVs were 1.3–5.3% and 0.4–3.8%, respectively. The method is precise and cost-effective and has been used successfully to determine the concentrations of DMG and betaine in human plasma and urine.




The following articles in journals at HighWire Press have cited this article:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. Schafer, L. Hoffmann, K. Heldt, M. R. Lornejad-Schafer, G. Brauers, T. Gehrmann, T. A. Garrow, D. Haussinger, E. Mayatepek, B. C. Schwahn, et al.
Osmotic regulation of betaine homocysteine-S-methyltransferase expression in H4IIE rat hepatoma cells
Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1089 - G1098.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. I. Holm, P. M. Ueland, G. Kvalheim, and E. A. Lien
Determination of Choline, Betaine, and Dimethylglycine in Plasma by a High-Throughput Method Based on Normal-Phase Chromatography-Tandem Mass Spectrometry
Clin. Chem., February 1, 2003; 49(2): 286 - 294.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.